Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot randomized open-label phase 3 trial of oral mesalazine MMx versus Asacol in active left-sided ulcerative colitis
2008-007292-25Phase 3Terminated
- Sponsor
- Giuliani
- Start
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of Salcrozine in autoimmune colitis (2 arms), sponsored by Giuliani. Primary endpoint: Colonic/rectal intramucosal concentration of 5-ASA. Started Mar 2009; status: terminated.
02
Drugs
Salcrozine
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on 2008-007292-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-007292-25.